COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1282: Articles 12811-12820  | Next

More rapid, robust and sustainable antibody responses to mRNA COVID-19 vaccine in convalescent COVID-19 individuals
Racine-Brzostek, S. E., Yee, J., Sukhu, A., Qiu, Y., Rand, S., Barron, P., Hao, Y., Yang, H. S., Meng, Q. H., Apple, F. S., Shi, Y., Chadburn, A., Golden, E., Formenti, S. C., Cushing, M., Zhao, Z.
10.1101/2021.08.04.21261561 — Posted: 2021-08-05
Increasing Numbers of Non-communicable Disease Co-morbidities: Major Risk Factors for Hospitalization among a Cohort of People with HIV and COVID-19 Coinfection
Virata, M., Shenoi, S., Villanueva, M., Ladines-Lim, J., Barakat, L.
10.1101/2021.08.03.21261560 — Posted: 2021-08-05
Learning about COVID-19 across borders: Public health information and adherence among international travellers to the UK
Cai, S., Zhang, T., Robin, C., Sawyer, C., Rice, W., Smith, L. E., Amlot, R., Rubin, G. J., Yardley, L., Hickman, M., Oliver, I., Lambert, H.
10.1101/2021.08.04.21261333 — Posted: 2021-08-05
SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors
Leon, J., Merrill, A., Rogers, K., Kurt, J., Dempewolf, S., Ehlers, A., Jackson, B., Knudson, M.
10.1101/2021.07.30.21261339 — Posted: 2021-08-05
Strategies to Estimate Prevalence of SARS-CoV-2 Antibodies in a Texas Vulnerable Population: Results from Phase I of the Texas Coronavirus Antibody REsponse Survey (TX CARES)
Valerio-Shewmaker, M. A., Desantis, S. M., Swartz, M. D., Yaseen, A., Gonzalez, M. O., Kohl, H. W., Kelder, S. H., Messiah, S. M., Aguillard, K. A., Breaux, C. J., Wu, L., Lakey, D., Shuford, J., Pont, S., Boerwinkle, E.
10.1101/2021.08.04.21261613 — Posted: 2021-08-05
Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases
Cook, C., Patel, N., D'Silva, K., Hsu, T. T.-Y., DiIorio, M., Prisco, L., Martin, L., Vanni, K. M. M., Zaccardelli, A., Todd, D. J., Sparks, J., Wallace, Z.
10.1101/2021.08.04.21261618 — Posted: 2021-08-05
Characterising COVID-19 empirical research production in Latin America and the Caribbean: a scoping review
Mansilla, C., Herrera, C. A., Boeira, L., Yearwood, A., Lopez, A. S., Colunga-Lozano, L. E., Brocard, E., Villacres, T., Velez, M., Di Paolantonio, G., Reveiz, L.
10.1101/2021.07.30.21261386 — Posted: 2021-08-05
Multiple-time measurements of multidimensional psychiatric states from immediately before the COVID-19 pandemic to one year later: A longitudinal online survey of the Japanese population
Oka, T., Kubo, T., Kobayashi, N., Nakai, F., Miyake, Y., Hamamura, T., Honjo, M., Toda, H., Boku, S., Kanazawa, T., Nagamine, M., Cortese, A., Takebayashi, M., Kawato, M., Chiba, T.
10.1101/2021.08.01.21261309 — Posted: 2021-08-05
Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): a longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection
O'Laughlin, K. N., Thompson, M., Hota, B., Gottlieb, M., Plumb, I. D., Chang, A. M., Wisk, L. E., Hall, A. J., Wang, R. C., Spatz, E., Stephens, K. A., Heubinger, R. M., McDonald, S. A., Venkatesh, A., Gentile, N., Slovis, B. H., Hill, M., Saydah, S., Idris, A. H., Rodriquez, R., Krumholz, H. M., Elmore, J. G., Weinstein, R. A., Nichol, G.
10.1101/2021.08.01.21261397 — Posted: 2021-08-05
Outbreak of SARS-CoV-2 in a prison: Low effectiveness of a single dose of the adenovirus vector ChAdOx1 vaccine in recently vaccinated inmates.
Marco, A., Teixido, N., Guerrero, R. A., Puig, L., Rue, X., Cobos, A., Barnes, I., Turu, E.
10.1101/2021.08.03.21258337 — Posted: 2021-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).